Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEBRIKIZUMAB-LBKZ vs LEDIPASVIR\SOFOSBUVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEBRIKIZUMAB-LBKZ vs LEDIPASVIR\SOFOSBUVIR: Safety Overview

Metric LEBRIKIZUMAB-LBKZ LEDIPASVIR\SOFOSBUVIR
Total FAERS Reports 726 23,616
Deaths Reported 2 1,371
Death Rate 0.3% 5.8%
Hospitalizations 19 4,031
Average Patient Age 50.3 yrs 57.9 yrs
% Female Patients 58.2% 42.9%
Marketing Status Prescription N/A